/ALHC
ALHC Stock - Alignment Healthcare, Inc.
Healthcare|Medical - Healthcare PlansNASDAQ
$20.42+0.05%
+$0.01 (+0.05%) • Dec 19
63
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.94
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).43
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.73
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+-3.3%upside
Target: $19.75
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ALHC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$20.22 – $20.62
TARGET (TP)$19.75
STOP LOSS$18.79
RISK/REWARD1:-0.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.16
52W High$21.06
52W Low$10.37
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.70B | $1.82B | $1.43B | $1.17B | $959.22M |
| Gross Profit | $296.69M | $201.03M | $184.28M | $128.73M | $166.23M |
| Gross Margin | 11.0% | 11.0% | 12.8% | 11.0% | 17.3% |
| Operating Income | $-101,555,000 | $-127,817,000 | $-128,639,000 | $-178,072,000 | $-5,263,000 |
| Net Income | $-128,035,000 | $-148,017,000 | $-149,547,000 | $-195,286,000 | $-22,926,000 |
| Net Margin | -4.7% | -8.1% | -10.4% | -16.7% | -2.4% |
| EPS | $-0.67 | $-0.79 | $-0.83 | $-1.14 | $-0.12 |
Company Overview
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
Visit WebsiteRating Distribution
Strong Buy
1
8%
Buy / Outperform
6
50%
Hold / Neutral
5
42%
Sell / Underperform
0%
Analyst Consensus🟡 Mixed
7 Bullish5 Neutral/Bearish
Price Targets
$12
Average Target
↓ 39.4% Downside
Now
$5
Low
$12
Average
$21
High
Based on 18 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 24th 2025 | JP Morgan | Upgrade | Overweight | $20 |
| October 14th 2025 | Goldman | Initiation | Buy | $21 |
| August 25th 2025 | KeyBanc Capital Markets | Upgrade | Overweight | $21 |
| July 31st 2025 | Barclays | Upgrade | Equal Weight | $13 |
| December 3rd 2024 | Stephens | Upgrade | Overweight | $17← $13 |
| October 11th 2024 | KeyBanc Capital Markets | Initiation | Sector Weight | - |
| May 30th 2024 | Robert W. Baird | Initiation | Outperform | $10 |
| May 30th 2024 | BofA Securities | Upgrade | Buy | $11← $7.75 |
| May 8th 2024 | Piper Sandler | Upgrade | Overweight | $8← $6 |
| March 6th 2024 | Barclays | Initiation | Underweight | $4.5 |
| March 6th 2024 | Piper Sandler | Downgrade | Neutral | $6← $12 |
| January 24th 2024 | Stifel | Initiation | Buy | $11 |
| November 2nd 2023 | BofA Securities | Downgrade | Neutral | $7.25← $7.5 |
| October 16th 2023 | Raymond James | Upgrade | Strong Buy | $10← $9 |
| October 12th 2023 | Stephens | Initiation | Equal Weight | $9 |
Earnings History & Surprises
ALHCBeat Rate
61%
Last 18 quarters
Avg Surprise
+28.9%
EPS vs Estimate
Beats / Misses
11/5
2 met exactly
Latest EPS
$0.02
Q4 2025
EPS Surprise History
Q1 24
-13.6%
$-0.25vs$-0.22
Q2 24
-4.2%
$-0.25vs$-0.24
Q3 24
+7.1%
$-0.13vs$-0.14
Q4 24
0.0%
$-0.14vs$-0.14
Q1 25
+11.1%
$-0.16vs$-0.18
Q2 25
+58.3%
$-0.05vs$-0.12
Q3 25
+200.0%
$0.07vs$-0.07
Q4 25
+300.0%
$0.02vs$-0.01
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 29, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | $-0.15 | — | — | — |
Q4 2025 | Oct 30, 2025 | $-0.01 | $0.02 | +300.0% | ✓ BEAT |
Q3 2025 | Jul 30, 2025 | $-0.07 | $0.07 | +200.0% | ✓ BEAT |
Q2 2025 | May 1, 2025 | $-0.12 | $-0.05 | +58.3% | ✓ BEAT |
Q1 2025 | Feb 27, 2025 | $-0.18 | $-0.16 | +11.1% | ✓ BEAT |
Q4 2024 | Oct 29, 2024 | $-0.14 | $-0.14 | 0.0% | = MET |
Q3 2024 | Aug 1, 2024 | $-0.14 | $-0.13 | +7.1% | ✓ BEAT |
Q2 2024 | May 2, 2024 | $-0.24 | $-0.25 | -4.2% | ✗ MISS |
Q1 2024 | Feb 27, 2024 | $-0.22 | $-0.25 | -13.6% | ✗ MISS |
Q4 2023 | Nov 2, 2023 | $-0.19 | $-0.19 | 0.0% | = MET |
Q3 2023 | Aug 3, 2023 | $-0.21 | $-0.15 | +28.6% | ✓ BEAT |
Q2 2023 | May 4, 2023 | $-0.25 | $-0.20 | +20.0% | ✓ BEAT |
Q1 2023 | Feb 28, 2023 | $-0.30 | $-0.31 | -3.3% | ✗ MISS |
Q4 2022 | Nov 3, 2022 | $-0.25 | $-0.22 | +12.0% | ✓ BEAT |
Q3 2022 | Aug 4, 2022 | $-0.26 | $-0.06 | +76.9% | ✓ BEAT |
Q2 2022 | May 5, 2022 | $-0.24 | $-0.23 | +4.2% | ✓ BEAT |
Q1 2022 | Mar 3, 2022 | $-0.28 | $-0.27 | +3.6% | ✓ BEAT |
Q4 2021 | Nov 4, 2021 | $-0.17 | $-0.26 | -52.9% | ✗ MISS |
Q3 2021 | Aug 9, 2021 | $-0.11 | $-0.25 | -127.3% | ✗ MISS |
Latest News
JP Morgan Maintains Overweight on Alignment Healthcare, Raises Price Target to $23
📈 PositiveBenzinga•Dec 17, 2025, 07:19 PM
Reuters: Some States Operating ACA Marketplaces Say Enrollment Is Significantly Down From Same Period Last Year, California Says ACA Enrollment Down By 33% vs Last Year
📉 NegativeBenzinga•Nov 24, 2025, 07:22 PM•Also: , ,
JP Morgan Upgrades Alignment Healthcare to Overweight, Raises Price Target to $20
📈 PositiveBenzinga•Nov 24, 2025, 12:37 PM
Politico Reported The White House To Propose A Two-year Extension Of Obamacare Subsidies With New Limits On Eligibility
➖ NeutralBenzinga•Nov 24, 2025, 11:16 AM•Also: , ,
JP Morgan Maintains Neutral on Alignment Healthcare, Raises Price Target to $18
➖ NeutralBenzinga•Nov 5, 2025, 07:29 PM
Barclays Maintains Equal-Weight on Alignment Healthcare, Raises Price Target to $18
➖ NeutralBenzinga•Nov 3, 2025, 02:19 PM•Also:
UBS Maintains Neutral on Alignment Healthcare, Raises Price Target to $18
➖ NeutralBenzinga•Oct 31, 2025, 03:37 PM
Alignment Healthcare shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 sales guidance above estimates. Also, the company raised its FY25 sales guidance above estimates.
📈 PositiveBenzinga•Oct 30, 2025, 08:42 PM
Alignment Healthcare Raises FY2025 Sales Guidance from $3.885B-$3.910B to $3.931B-$3.946B vs $3.901B Est
📈 PositiveBenzinga•Oct 30, 2025, 08:03 PM
Alignment Healthcare Sees Q4 Sales $995.000M-$1.010B vs $978.058M Est
📈 PositiveBenzinga•Oct 30, 2025, 08:03 PM
Alignment Healthcare Q3 EPS $0.02 Beats $(0.09) Estimate, Sales $993.695M Beat $981.352M Estimate
📈 PositiveBenzinga•Oct 30, 2025, 08:01 PM
Goldman Sachs Initiates Coverage On Alignment Healthcare with Buy Rating, Announces Price Target of $21
📈 PositiveBenzinga•Oct 14, 2025, 12:36 PM•Also:
Alignment Healthcare Secures 100% Enrollment In 4-Star+ Medicare Advantage Plans For Second Straight Year, Per CMS Ratings
📈 PositiveBenzinga•Oct 10, 2025, 12:06 PM
Keybanc Upgrades Alignment Healthcare to Overweight, Announces $21 Price Target
📈 PositiveBenzinga•Aug 25, 2025, 11:32 AM
Frequently Asked Questions about ALHC
What is ALHC's current stock price?
Alignment Healthcare, Inc. (ALHC) is currently trading at $20.42 per share. The stock has moved +0.05% today.
What is the analyst price target for ALHC?
The average analyst price target for ALHC is $19.75, based on 1 analyst.
What sector is Alignment Healthcare, Inc. in?
Alignment Healthcare, Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Plans industry. The company is traded on the NASDAQ exchange.
What is ALHC's market cap?
Alignment Healthcare, Inc. has a market capitalization of $4.09 billion, making it a mid-cap company.
Does ALHC pay dividends?
No, Alignment Healthcare, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAPGE
Apogee Therapeutics, Inc.
$78.54
Mkt Cap: $4.3B
DYN
Dyne Therapeutics, Inc.
$19.85
Mkt Cap: $2.8B
GRAL
GRAIL, Inc.
$91.09
Mkt Cap: $3.2B
ICUI
ICU Medical, Inc.
$145.15
Mkt Cap: $3.6B
MIRM
Mirum Pharmaceuticals, Inc.
$77.74
Mkt Cap: $3.8B
NVST
Envista Holdings Corp
$22.28
Mkt Cap: $3.7B
OSCR
Oscar Health, Inc.
$14.90
Mkt Cap: $3.8B
PRVA
Privia Health Group, Inc.
$23.64
Mkt Cap: $2.9B
RARE
Ultragenyx Pharmaceutical Inc.
$33.50
Mkt Cap: $3.2B
SLNO
Soleno Therapeutics, Inc.
$47.85
Mkt Cap: $2.6B
Explore stocks similar to ALHC for comparison